BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11148045)

  • 21. Role of the activation loop tyrosines in regulation of the insulin-like growth factor I receptor-tyrosine kinase.
    Li W; Miller WT
    J Biol Chem; 2006 Aug; 281(33):23785-91. PubMed ID: 16793764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic effects of autophosphorylation on receptor tyrosine kinase catalysis: enzymatic characterization of Tie2 and phospho-Tie2.
    Murray BW; Padrique ES; Pinko C; McTigue MA
    Biochemistry; 2001 Aug; 40(34):10243-53. PubMed ID: 11513602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: insights into kinase mechanism.
    Till JH; Ablooglu AJ; Frankel M; Bishop SM; Kohanski RA; Hubbard SR
    J Biol Chem; 2001 Mar; 276(13):10049-55. PubMed ID: 11124964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis.
    Parast CV; Mroczkowski B; Pinko C; Misialek S; Khambatta G; Appelt K
    Biochemistry; 1998 Nov; 37(47):16788-801. PubMed ID: 9843450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleotide release and associated conformational changes regulate function in the COOH-terminal Src kinase, Csk.
    Shaffer J; Sun G; Adams JA
    Biochemistry; 2001 Sep; 40(37):11149-55. PubMed ID: 11551213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cis-autophosphorylation of juxtamembrane tyrosines in the insulin receptor kinase domain.
    Cann AD; Kohanski RA
    Biochemistry; 1997 Jun; 36(25):7681-9. PubMed ID: 9201908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to insulin receptor tyrosine kinase stimulate its activity towards exogenous substrates without inducing receptor autophosphorylation.
    Baron V; Gautier N; Rochet N; Ballotti R; Rossi B; Saint-Pierre S; Van Obberghen E; Dolais-Kitabgi J
    Biochem J; 1989 Jun; 260(3):749-56. PubMed ID: 2764902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity.
    Bollag GE; Roth RA; Beaudoin J; Mochly-Rosen D; Koshland DE
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5822-4. PubMed ID: 3526339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail.
    Wang D; Huang XY; Cole PA
    Biochemistry; 2001 Feb; 40(7):2004-10. PubMed ID: 11329267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.
    Dougher M; Terman BI
    Oncogene; 1999 Feb; 18(8):1619-27. PubMed ID: 10102632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Zap-70 tyrosine kinase due to a structural rearrangement induced by tyrosine phosphorylation and/or ITAM binding.
    Visco C; Magistrelli G; Bosotti R; Perego R; Rusconi L; Toma S; Zamai M; Acuto O; Isacchi A
    Biochemistry; 2000 Mar; 39(10):2784-91. PubMed ID: 10704231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain.
    Wei L; Hubbard SR; Hendrickson WA; Ellis L
    J Biol Chem; 1995 Apr; 270(14):8122-30. PubMed ID: 7713916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and enzyme activity of ACK1.
    Yokoyama N; Miller WT
    Methods Enzymol; 2006; 406():250-60. PubMed ID: 16472662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replacement of the conserved tyrosine 1210 by phenylalanine in the insulin receptor affects insulin-induced dephosphorylation of focal adhesion kinase but leaves other responses intact.
    Van der Zon GC; Ouwens DM; Dorrestijn J; Maassen JA
    Biochemistry; 1996 Aug; 35(32):10377-82. PubMed ID: 8756693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-specific dephosphorylation and deactivation of the human insulin receptor tyrosine kinase by particulate and soluble phosphotyrosyl protein phosphatases.
    King MJ; Sharma RP; Sale GJ
    Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):413-8. PubMed ID: 1850986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tyrosine kinase activity of the chicken insulin receptor is similar to that of the human insulin receptor.
    Kato H; Okubo Y; Matsumura Y; Roberts CT; Sugahara K; LeRoith D
    Biosci Biotechnol Biochem; 2000 Apr; 64(4):903-6. PubMed ID: 10830518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrostatic environment surrounding the activation loop phosphotyrosine in the oncoprotein v-Fps.
    Leon BC; Tsigelny I; Adams JA
    Biochemistry; 2001 Aug; 40(34):10078-86. PubMed ID: 11513586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catalysis of serine and tyrosine autophosphorylation by the human insulin receptor.
    Baltensperger K; Lewis RE; Woon CW; Vissavajjhala P; Ross AH; Czech MP
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7885-9. PubMed ID: 1381504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient state kinetic studies of the MutT-catalyzed nucleoside triphosphate pyrophosphohydrolase reaction.
    Xia Z; Azurmendi HF; Mildvan AS
    Biochemistry; 2005 Nov; 44(46):15334-44. PubMed ID: 16285737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.